Categories: News

Integrated Investment Research Q2 Earnings Up from Q1

Tokyo, Japan, August 01, 2020 –(PR.com)– Integrated Investment Research release Q2 earnings report up 39.3% from Q1.

Chief Finance Officer Heng Lim spoke about the results. “It has been an indifferent year after Q1 results having dropped slightly from the Previous Quarter; it was important to get a positive result for Q2. We have managed to achieve this mainly due to the fact we have been investing heavily into the gold market which has allowed our clients and Integrated Investment Research to reap the results.

“We are expecting more of the same in Q3 as a 2nd wave becomes a reality around the world, this will only have further impact on the financial markets and for now our stance on gold will not change. Integrated Investment Research see the price of gold rising to the $2,200 level by year end.”

Let’s block ads! (Why?)

Miscw.com

Recent Posts

Hong Kong Design Centre Welcomes ‘Blueprint for Arts and Culture and Creative Industries Development’

HONG KONG SAR - Media OutReach Newswire - 27 November 2024 - Hong Kong Design…

20 minutes ago

Preserving the beauty of nature – a bond that links Lancang-Mekong countries

CHENGDU CITY, CHINA - Media OutReach Newswire - 27 November 2024 - Taking its source…

20 minutes ago

Arirang TV presents Korea’s one-day trip entertainment show “¡Hola, Corea!” for South American viewers

- Arirang TV's one-day trip entertainment “¡Hola, Corea!”, specially produced for South American viewers, will…

2 hours ago

Gartner Announces the Gartner CFO & Finance Executive Conference 2025 in Sydney

--(BUSINESS WIRE)--Gartner, Inc. (NYSE: IT): What:   Gartner CFO and Finance Executive Conference 2025  …

2 hours ago

Northern Trust Asset Management 2025 Global Investment Outlook: Expect U.S. Stocks to Outperform; High Yield Bond Market Is Attractive

Earnings Growth Backs U.S. Equities; Strong Credit Quality Supports High Yield Market; U.S. Money Market…

2 hours ago

S.BIOMEDICS Investigational Cell Therapy for Parkinson’s Disease With TED-A9 Shows Positive Data at 12-months in Phase 1/2a Clinical Trial

TED-A9 is high-purity ventral midbrain dopaminergic progenitor cells derived from human embryonic stem cells (hESCs)…

2 hours ago